AptarGroup, Inc. a global leader in drug and consumer product dosing, dispensing and protection technologies, announces the commencement of a clinical study to validate its proprietary SmartTrack™ platform.
Bruker Corporation announced a majority investment in RECIPE Chemicals + Instruments GmbH, based in Munich, Germany. RECIPE is a leading European provider of vendor-agnostic therapeutic drug monitoring (TDM) and other clinical in vitro diagnostic kits for LC-MS/MS, HPLC, and ICP-MS assays.
Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, announces the positive results from the SPEED1 survey, showcasing the impact of the iPUMP® connected assistant on adherence to Stallergenes Greer’s sublingual liquid immunotherapy (SLIT).
Bruker´s Microbiology and Infection Diagnostics division is announcing the expansion of its microbiology solutions into Next-Generation Sequencing (NGS) applications, with new, research-use only NGS-based solutions in epidemiology and hospital acquired infection (HAI) tracing.
Accuray Incorporated announced that new data on the clinical use of the CyberKnife® System reinforce the device's broad-based radiation treatment capabilities for central nervous system (CNS) tumors. Malignant brain and other CNS tumors are considered to be some of the most fatal types of cancer and contribute to significant morbidity and mortality in the United States.
Bruker Corporation, the leading provider of Nuclear Magnetic Resonance (NMR) spectroscopy solutions, announced the launch of an innovative Fourier 80 multinuclear benchtop FT-NMR spectrometer, known as the ‘Multi-Talent’ configuration.
Cognito Therapeutics, a pioneering neurotechnology company developing disease-modifying therapies for neurodegenerative diseases, announced new data from its OVERTURE feasibility trial at the AD/PD™ 2025 International Conference on Alzheimer’s and Parkinson’s Diseases.
GoodRx the leading platform for medication savings in the U.S., announced a new e-commerce experience for retail pharmacies that improves how consumers get their medications via the GoodRx platform. The company is launching the experience with Midwest-based retailer Hy-Vee.
Sierra Space, a leading commercial space company and defense tech prime that is Building a Platform in Space to Benefit Life on Earth,® and Yuri, a Germany-based space biotech company, announced an agreement for one new ScienceTaxi BioSpin mission to continue biological and medical research advancements and drug discovery in microgravity. The culmination of the partnership will ultimately aim to provide scientific solutions for treating and curing diseases on Earth.
Pint Pharma and PharmaEssentia announced that ANVISA (Brazilian Health Regulatory Agency) has approved BESREMi® (ropeginterferon alfa-2b) for the treatment of adult patients with Polycythemia Vera (PV).